Monden Y, Nakahara K, Nanjo S, Fujii Y, Matsumura A, Masaoka A, Kawashima Y
Cancer. 1984 Dec 1;54(11):2513-8. doi: 10.1002/1097-0142(19841201)54:11<2513::aid-cncr2820541133>3.0.co;2-i.
In 261 surgically treated patients with myasthenia gravis (MG), 26 had an invasive thymoma and 49 had a noninvasive thymoma. Invasive thymoma was seen in 41% of thymomatous MG patients older than 40 years of age, and 28% in patients younger than 40 years of age. Of 19 patients who underwent total or subtotal thymothymomectomy accompanied by irradiation (4000 rad), 17 were still alive on an average 6.5 years after surgery. The deterioration of MG by the irradiation was observed in 7 of 20 irradiated cases. Thus, postoperative irradiation is effective but should be done with attention to the deterioration of MG. The prognosis of MG in patients with an invasive thymoma was poorer than that in patients with a noninvasive thymoma.
在261例接受手术治疗的重症肌无力(MG)患者中,26例患有侵袭性胸腺瘤,49例患有非侵袭性胸腺瘤。40岁以上的胸腺瘤型MG患者中,41%患有侵袭性胸腺瘤;40岁以下的患者中,这一比例为28%。在19例接受全胸腺或次全胸腺切除术并辅以放疗(4000拉德)的患者中,17例术后平均存活6.5年。在20例接受放疗的病例中,有7例出现了因放疗导致的MG病情恶化。因此,术后放疗是有效的,但应注意MG病情的恶化。侵袭性胸腺瘤患者的MG预后比非侵袭性胸腺瘤患者差。